1 Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73190; 2 Pulmonary Division, Beth Israel Deaconess Medical Center, and 3 Ina Sue Pelmutter Laboratory, Children's Hospital, Harvard Medical School, Boston, Massachusetts 02215; 4 Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, Wisconsin 53706; and 5 Department of Pediatrics, State University of New York, Health Science Center at Brooklyn, Brooklyn, New York 11203-2098
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The role
of neurokinin-1 receptors (NK1R) in the interaction between mast cells
and substance P (SP) in bladder inflammation was determined. Mast
cell-deficient KitW/KitW-v, congenic
normal (+/+), and KitW/KitW-v mice
that were reconstituted with bone marrow cells isolated from
NK1R/
mice were challenged by instillation of SP,
antigen, or saline into the urinary bladder. Twenty-four hours after
challenge, the bladders were prepared for morphological assessment and
gene expression. SP-induced bladder inflammation was mast cell
dependent and did not require NK1R expression on the mast cell. Cluster
analysis identified functionally significant genes that were dependent on the presence of mast cells for their upregulation regardless of
stimulus. Those include serine protein inhibitor 2.2, maspin, mitogen-
and stress-activated protein kinase 2, and macrophage colony-stimulating factor 1. Our findings demonstrate that while mast
cells are essential for both antigen- and SP-induced bladder inflammation, there are common genes and unique genes expressed in each
type of inflammatory reaction. When combined with unique animal models,
gene array analysis provides a useful approach for identifying and
characterizing pathways involved in bladder inflammation.
transgenic/knockout; mast cells; inflammation; gene regulation; protein kinases/phosphatases
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
INFLAMMATION UNDERLIES ALL major bladder pathologies. Indeed, areas of bladder inflammation are found during chronic implantation of catheters (22, 88), as an integrative part of bladder responses to intravesical bacillus Calmette-Guerin (BCG) (10, 12) and capsaicin therapy (34), during radiation cystitis, and in cyclophosphamide-induced cystitis (86, 87), interstitial cystitis (28, 68), and bladder cancer (3-13).
Chronic inflammation in the bladder mucosa is typical in spinal cord-injured patients with a chronic indwelling bladder catheter (22, 88). Inflammation is also observed secondarily to intravesical treatments. Indeed, inflammation is part of the response to intravesical BCG instillation. However, some authors have reported that BCG inflammation obviously differs from nonspecific inflammation by its quality and subclinical duration (12), whereas others have qualified BCG-induced bladder inflammation as granulomatous (10). In addition, inflammation does not explain BCG immunotherapy for superficial bladder carcinoma; this complex response requires an immune response as well as a tumor response for its effects (43). Inflammation occurs also secondarily to intravesical capsaicin therapy for detrusor hyperreflexia (34), and part of this response is modulated by ethanol, used as a vehicle for capsaicin (23).
Inflammation seems to underlie bladder cancer. In this context, epidemiological studies indicate that the development of squamous cell carcinoma of the urinary bladder is closely associated with chronic inflammation of the urinary tract. Chronic inflammation was present in all cases; radiation-induced pseudocarcinomatous proliferations of the urinary bladder (3) and chronic subepithelial inflammation are also commonly present in intraepithelial neoplasms (13).
It seems that the very same cells and molecules that mediate bladder
inflammation and the response to pathogens and trauma are integral
parts of bladder cancer processes. Indeed, adhesion molecules known to
have a role in inflammation are now being postulated to play a central
role in the development and progression of bladder cancer
(79). Another molecule that participates in bladder
inflammation and cancer is IL-6. IL-6 is the primary cytokine elevated
in the urine of interstitial cystitis patients (26). IL-6
functions as an autocrine growth factor for bladder carcinoma cells but not for normal urothelial cells, and it may be a factor accounting for
the marked enhancement of inflammation-associated bladder carcinogenesis and tumor growth (60). A common pathway
leading to a bladder response to inflammatory stimuli is NF-B
(89). A central role for NF-
B in bladder inflammation
was proposed on the basis of the finding that this transcription factor
stimulates the expression of enzymes whose products contribute to the
pathogenesis of the inflammatory process, including the inducible form
of nitric oxide synthase and inducible cyclooxygenase-2
(61). Abnormalities in the regulation of the NF-
B
pathway are frequently seen in a variety of human malignancies
including leukemias, lymphomas, and solid tumors (66).
These abnormalities result in constitutively high levels of NF-
B in
the nucleus of a variety of tumors including breast, ovarian, prostate,
and colon cancers.
Neuroimmune mechanisms have been suggested to play an important role in
the development of inflammatory reactions in the urinary bladder
(40). One potential pathway that may mediate such
neurogenic inflammation is the interaction between mast cells and the
neurotransmitter substance P. The responses to substance P and other
tachykinins such as neurokinin A, neurokinin B, and hemokinin B are
mediated by three different G protein-coupled neurokinin receptors via changes in cytosolic calcium concentration (90).
Neurokinin-1 (NK1) receptors (NK1Rs) are the predominant
receptor subtype involved in inflammation and are expressed by
endothelial cells, submucosal glands, and circulating leukocytes
(85). In the urinary bladder, plasma extravasation induced
by substance P seems to be modulated by NK1Rs, because it was inhibited
by a specific receptor antagonist (33). More recently, we
presented evidence of increased NK1R density during bladder
inflammation (39). In addition, we have shown that in the
urinary bladder, substance P receptors (NK1Rs) are downstream of
NF-B activation and that NK1R knockout mice failed to mount a
bladder inflammatory response (89). Others have shown an
increase in NK1R numbers, and distribution may underlie persistent pain
such as that observed during chronic inflammation (1, 9,
55). In contrast, NK2Rs mediate detrusor muscle contraction in
humans (63, 95), dogs (56, 71), hamsters (83), and mice (57), whereas NK3Rs have been
found in the ganglia (35) and vascular smooth muscle
(45), but they have yet to be identified in the urinary
system (4).
Although there is considerable evidence that NK1Rs seem to play a critical role in the transmission of noxious stimuli (9, 47), NK1R antagonists were described to be of low efficacy in the clinical treatment of pain (41). The apparently low efficacy of NK1R antagonists in the treatment of pain in humans has been attributed to inadequate clinical trials (84). Alternatively, several dual antagonists of NK1Rs and NK2Rs have been developed (67, 77). With the exception of ZD-6021, which has been shown to dose dependently attenuate plasma extravasation in guinea pigs (6), little if any investigation of the therapeutic potential of dual antagonists has been done. Alternatively, several authors have used a combination of NK1, NK2, and NK3 antagonists to reduce visceral hyperalgesia (44).
Sensory nerves within the bladder contain high concentrations of
substance P, which is a potent inducer of mast cell degranulation (93). In addition, mast cells are found in increased
numbers in bladder biopsies obtained from patients with interstitial
cystitis (42, 62), suggesting that mast cells potentially
influence this condition. The release of mast cell mediators such as
histamine, proteases, arachidonic acid metabolites, and TNF- and
other cytokines can potentially initiate and/or amplify inflammatory
responses in the bladder (32) by stimulating sensory
nerves to release substance P (11). Indeed, the
inflammatory responses to mast cell tryptase are mediated through
substance P release (21). This indirect evidence implies a
link between substance P and mast cells in the pathogenesis of bladder
inflammation, but a definitive demonstration of such a
pathophysiological relation is lacking.
One area of controversy that continues to limit our understanding of substance P-mast cell interactions is the mechanism through which substance P induces mast cell degranulation. In other systems, tachykinins such as substance P interact with a family of receptors termed neurokinin receptors. The high-affinity receptor for substance P is NK1R. A straightforward speculation has been that substance P interacts with NK1Rs on mast cells. However, there is conflicting evidence in the literature as to whether mast cells express NK1Rs or whether substance P induces mast cell activation through an alternative, receptor-independent mechanism.
For example, evidence supporting mast cell expression of NK1Rs includes
radiolabel binding assays suggestive of a single high-affinity binding
site for substance P on freshly isolated rat peritoneal mast cells
(PMCs) (59), the ability to inhibit substance P-induced degranulation of rat PMCs (58, 59) and a murine mast cell line (46) with specific NK1R antagonists, and the
identification of NK1R mRNA by RT-PCR in freshly isolated PMCs
(59). However, many of these findings using rat PMCs
appear to depend on the strain of rat studied (58, 59).
Similarly, the presence of NK1R mRNA was found in cultured RBL-2H3
cells, a rat mast cell line (18). By contrast, substantial
evidence supports the concept that substance P induces mast cell
degranulation by direct activation of certain G proteins (2,
53). Experiments using labeled substance P and patch-clamp
techniques indicate that substance P translocates into mast cells and
activates degranulation by a pertussis toxin- and GDPS-sensitive
mechanism (53). Our group and others have been
investigating the role of substance P and NK1Rs in experimental
cystitis. Our laboratory previously reported a mouse model of
antigen-induced bladder inflammation characterized by histological
evidence of mast cell degranulation, edema, and infiltration of the
bladder by neutrophils (73). Using genetically engineered
mice deficient in the expression of NK1Rs, we were able to directly
evaluate the importance of NK1-substance P interactions in
the development of cystitis. We reported that NK1R
/
mice exhibited no inflammation in response to antigen challenge, indicating that NK1Rs play a critical role in antigen-induced inflammation and suggesting that substance P is involved in the pathogenesis of this response (73).
In a separate study, we investigated the role of mast cells in this antigen-induced model of bladder inflammation (72). For this purpose, we examined the responses in mast cell-deficient KitW/KitW-v, congenic normal (+/+), and KitW/KitW-v mice that were reconstituted with +/+ bone marrow cells (BMR-KitW/KitW-v). This procedure repopulates mast cells and other bone marrow-derived elements in KitW/KitW-v mice. Antigen-induced bladder inflammation occurred in +/+ and BMR-KitW/KitW-v mice but not in mast cell-deficient KitW/KitW-v mice. Gene expression was determined using mouse cDNA expression arrays and indicated that gene expression associated with the inflammatory response was dependent on the presence of mast cells, i.e., certain genes were upregulated in bladders isolated from antigen-challenged +/+ and BMR-KitW/KitW-v mice but were not altered in KitW/KitW-v mice. Taken together, these studies indicate an important role for mast cells and NK1Rs in this antigen-induced model of cystitis (72-73) but do not address the nature of the interaction of substance P and mast cells.
Thus to more precisely define the role of mast cells and NK1Rs in experimental bladder inflammation, we examined the bladder inflammatory reactions in +/+, mast cell-deficient KitW/KitW-v, and BMR-KitW/KitW-v mice. The controversy concerning the expression of NK1Rs on mast cells aside, this model would permit us to examine experimental cystitis in the absence of mast cells in a host that expresses NK1Rs and then compare the reactions in the same host that now has mast cells that do not, and cannot, express NK1Rs.
![]() |
METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Reagents. Dinitrophenyl (DNP) was conjugated to ovalbumin (OVA) or human serum albumin (HSA; Sigma, St. Louis, MO) as previously described (52). Alum was purchased from Intergen (Purchase, NY) and used as an adjuvant. Substance P was purchased from Sigma. All reagents were prepared in pyrogen-free saline immediately before use.
Animals. All animal experimentation described here was performed in conformity with the "Guiding Principles for Research Involving Animals and Human Beings" (Oklahoma University Health Sciences Center Animal Care and Use Committee, protocol no. 00-109).
Three groups of 10- to 12-wk-old female mice were used in experiments. NK1RBone marrow reconstitution of mast cell-deficient
KitW/KitW-v mice.
Mice with double mutations at the W loci have a variety of
phenotypic abnormalites, including a profound deficiency in the numbers
of tissue mast cells, macrocytic anemia, age-dependent changes in
intraepithelial lymphocyte populations in the gastrointestinal tract,
and other nonmyeloid abnormalites (92). Bone marrow
transplantation repairs both the mast cell deficiency and the anemia in
KitW/KitW-v mice (92).
We utilized this approach to reconstitute
KitW/KitW-v mice with bone marrow
from NK1R/
mice, and thus the mast cells that develop
in the bladder would not be capable of expressing the NK1R.
Antigen sensitization protocol. All mice in this study were sensitized intraperitoneally with 1 µg DNP4-HSA in 1 mg alum on days 0, 7, 14, and 21. In normal mice, this protocol induces sustained levels of IgE antibodies up to 56 days postsensitization (38), and mast cell-deficient KitW/KitW-v mice have been shown to develop normal IgE responses in similar active immunization protocols (30). One week after the last sensitization, an inflammatory reaction was elicited in the bladder (see Induction of experimental cystitis).
Induction of experimental cystitis.
Cystitis was induced as described previously (69-70,
72-73). Briefly, sensitized
KitW/KitW-v, +/+, and
BMR-NK1R/
mice were anesthetized (40 mg/kg ketamine and
2.5 mg/kg xylazine ip), transurethrally catheterized (Angiocath,
Becton Dickinson, Sandy, UT), and drained of any urine present by the
application of slight digital pressure to the lower abdomen. The
urinary bladders were instilled with 150 µl of either pyrogen-free
saline, substance P (10 µM), or DNP4-OVA (antigen; 1 µg/ml), infused at a slow rate to avoid trauma and vesicoureteral
reflux. To ensure consistent contact of substances with the bladder,
infusion was repeated twice within a 30-min interval, and a 1-ml Tb
syringe maintained on the catheter retained the intravesical solution
for at least 1 h. The catheter was then removed, and the mice were
allowed to void normally. Twenty-four hours after challenge, the mice were killed with pentobarbital sodium (20 mg/kg ip) and bladders were removed.
Histological assessment of bladder inflammation. A cross section of bladder wall was fixed in formalin, dehydrated in graded alcohol and xylene, embedded in paraffin, and cut serially into four 5-µm sections (8 µm apart) stained with either hematoxylin and eosin or Giemsa. The urinary bladders were evaluated for the presence of edema, extent of inflammatory cell accumulation, and number of mast cells present. A semiquantitative score using defined criteria of inflammation severity was used to evaluate cystitis (69, 70, 72, 73). Slides were scanned using a Nikon digital camera (DXM1200) mounted on a Nikon microscope (Eclipse E600). Image analysis was performed using the MetaMorph Imaging System (Universal Imaging, West Chester, PA). The severity of lesions in the urinary bladder was graded as follows: 1+, mild (minimal infiltrate of neutrophils in the lamina propria and little or no interstitial edema); 2+, moderate (infiltration of neutrophils into the lamina propria and moderate interstitial edema); and 3+, severe (diffuse infiltration of a large number of neutrophils in the lamina propria and severe interstitial edema) (73). Identification of mast cells and quantification of their degree of degranulation was performed in Giemsa-stained sections. The extent of degranulation is presented as the percentage of mast cells per cross section that exhibited morphological evidence of degranulation.
Sample preparation for cDNA expression arrays. cDNA expression arrays were performed as previously described (69, 72). Briefly, three bladders from each group were pooled and homogenized in Ultraspec RNA solution (Biotecx Laboratories, Houston, TX) for isolation and purification of total RNA (we had previously determined that the pooling of 3 bladders is necessary to provide enough RNA for gene array analysis). RNA was DNAse treated according to the manufacturer's instructions (Clontech Laboratories, Palo Alto, CA), and the quality of 10 µg RNA was evaluated by denaturing formaldehyde-agarose gel electrophoresis. This procedure was replicated using an additional three bladders per each experimental group. Therefore, two pools of RNA were generated per experimental group, and two separate hybridizations were performed per group.
cDNA probes prepared from each of the experimental groups were hybridized simultaneously to membranes containing Atlas Mouse 1.2 Arrays (78531, Clontech; for a complete list of genes present in this array, see http://www.clontech.com/atlas/genelists/index.html). Briefly, 5 µg of DNAse-treated RNA were reverse transcribed to cDNA and labeled with [Background subtraction.
Background represented by empty rows and columns was averaged. This
background intensity was deducted from the intensity of each spot. In
addition, the intensity of negative controls M13 mp18 (+) strand DNA,
-DNA, and pUC18 DNA were taken as unspecific hybridization and
averaged. This unspecific hybridization was deducted from the intensity
of each spot. Only signals with 3 SD above background were used. This
was done to avoid ratios either mathematically impossible or
astronomically high. The values for all genes with
background-subtracted intensities >1 were then exported to an Excel
spreadsheet to generate a sorted data matrix for all arrays within each
experiment. At this point, data were filtered to eliminate genes
detected fewer than two times in each condition and replicate array
values normalized by the sum-of-intensities method. Total intensities
from the two conditions were then scaled, and mean intensities were
calculated for scatterplot visualization of the fold-changes. The
signal intensities were normalized to the mean signal intensity of all
the spots on the array. Duplicate spots of each cDNA were averaged. To
compare two arrays (2 conditions), expression was calculated as the
percentage of
-actin, as previously described (72).
Experimental criteria.
To determine which genes were dependent on the presence of tissue mast
cells but independent of NK1Rs, we set the following arbitrary
criteria: 1) the gene should be upregulated at least threefold in response to antigen or substance P challenge in +/+ tissues; 2) the same gene should not be upregulated in the
absence of mast cells (KitW/KitW-v
mice); and 3) upregulation should be demonstrated in
BMR-NK1R/
mice.
Cluster analysis using self-organizing maps.
Genes fulfilling the above criteria were identified on the basis of a
Euclidean distance metric, after the elimination of genes that failed
to vary in expression level within an experiment by a factor of 3 SE
and an absolute value of 100% of -actin and normalization within
experiments to a mean of 0 and an SD of 1.
![]() |
Data preprocessing. Using GeneCluster, SOMs were constructed by choosing a 6 × 4 grid that generated 24 clusters. It was also our concern to present as few clusters as possible that would still give a clear picture of substance P- and antigen-induced gene expression. Increasing the number of clusters by increasing the grid did not gave us any additional correlation between genes. A variation filter was used to eliminate genes that did not change significantly across samples.
Array reproducibility. To determine the reproducibility of the arrays, we performed a regression analysis using an Excel spreadsheet. This test compared the results obtained with two pools of RNA isolated from sensitized wild-type mice that were challenged with saline and hybridized separately. The same analysis was performed using RNA isolated from sensitized wild-type mice that were challenged with antigen and substance P.
Venn diagrams.
For representations of the numbers of genes up- or downregulated in
each group as well as genes common to two or more groups, we used Venn
diagram analysis performed by GeneSpring software [Silicon Genetics,
Redwood City, CA
(http://www.silicongenetics.com/cgi/SiG.cgi/index.smf.)] using raw
data and filtering genes that were upregulated at least threefold in a
comparison of substance P-, antigen-, and saline-challenged bladders
isolated from +/+ , KitW/KitW-v, and
BMR-NK1R/
mice. Another set of analyses was performed
by comparing genes upregulated or downregulated in antigen- and
saline-challenged groups. Finally, we determined genes that satisfied
all three conditions in response to either antigen or substance P.
Statistical analysis.
For each group, 1,200 genes were analyzed by 2 different
hybridizations using 2 different pools of RNA isolated from sensitized KitW/KitW-v, +/+, and
BMR-NK1R/
mice that were challenged with saline,
antigen, or substance P. Therefore, a total of 21,600 data points were
analyzed. SOMs were constructed by choosing a 6 × 4 grid that
generated 24 clusters. As this type of analysis assumes that the data
can be divided into a certain number of clusters and that they are well
separated, it was also our concern to present the fewest clusters
possible that would still give a clear picture of antigen- and
substance P-induced gene expression. Increasing the number of clusters
by increasing the grid did not produce any additional correlation between genes. GeneCluster software provides a list of genes present in
each cluster and a centroid. However, to permit comparisons, in each
cluster, gene expression was averaged and the SE was calculated. In
each cluster, comparisons between gene regulation in response to
antigen or substance P challenge were obtained by the ratio of gene
expression in relation to the corresponding saline group. Significant
differences were determined using an unpaired Student's t-test. The statistical analysis of histological data was
performed using Wilcoxon's rank-sum test. Results are expressed as
means ± SE. The n values reported refer to the number
of animals used for each experiment. In all cases, a value of
P < 0.05 was considered to represent a significant difference.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Morphological assessment of substance P-induced cystitis. We recently reported that mast cells were critical to the inflammatory response and gene expression associated with antigen-induced cystitis (72). In that study, we validated the approach of repopulating bladder mast cells in mast cell-deficient KitW/KitW-v mice by transplantation of bone marrow from normal +/+ mice (BMR-KitW/KitW-v).
Using a similar approach, we now examined the histological changes and requirement for NK1R expression on mast cells during substance P-induced cystitis. For this study, normal +/+, mast cell-deficient KitW/KitW-v, and BMR-NK1R
|
Reproducibility of array hybridization.
We previously presented evidence of the reproducibility of gene array
methodology for the analysis of bladder inflammatory genes (69,
72) and verified the results using RNase protection assays
(69). In the present work, we determined the
reproducibility of our hybridization technique by performing regression
analysis from values obtained with two different pools of RNA. Figure
1A represents regression
analysis of RNA isolated from the bladder of sensitized +/+ mice that
were challenged with saline (Fig. 1A). Similar analysis was
performed using RNA isolated from the bladder of +/+ mice that were
challenged with either substance P (Fig. 1B) or antigen
(Fig. 1C). The calculated correlation coefficients for +/+
mice challenged with saline, antigen, or substance P were 0.9838, 0.9628, and 0.9718, respectively.
|
Role of mast cell NK1R expression on gene expression during
experimental cystitis.
Figure 2 is a Venn diagram showing the
genes that were upregulated at least threefold in each animal group
24 h after substance P or antigen challenge (Fig. 2, A
and B, respectively). The diagram indicates genes commonly
upregulated between two or more groups. Interestingly, the genes
expressed by mast cell-deficient
KitW/KitW-v mice as a result of
antigen challenge differed fundamentally from those observed with
substance P challenge. In the mast cell-deficient KitW/KitW-v mice, only 13 genes were
uniquely expressed after antigen challenge compared with 128 genes
upregulated in response to substance P. In addition, the Venn diagram
also highlights genes that were dependent on tissue mast cells for
their upregulation but independent of the presence of NK1R on the mast
cells. Thirty-two genes in the group of antigen-challenged mice and 21 genes in the group challenged with substance P fulfilled our criteria
of being upregulated at least 3-fold in tissues isolated from +/+ and
BMR-NK1R/
but not in tissues isolated from mast
cell-deficient KitW/KitW-v mice. In
the presence of mast cells, only four genes were always upregulated in
either inflammatory response (antigen or substance P). Those genes are
represented by cluster 1 (Fig.
3A; Table
2) and include serine protease
inhibitor (Spi) 2.2 (M64086), maspin (U54705), mitogen- and
stress-activated protein kinase 2 (MSK2; AF074714), and macrophage
colony-stimulating factor 1 (CSF-1 or M-CSF; X05010).
|
|
|
|
|
|
|
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Several lines of indirect evidence suggest that substance P-mast cell interactions are involved in the development of interstitial cystitis. We now provide direct evidence that mast cells play a critical role in the pathogenesis of substance P-induced cystitis in mice. In the absence of mast cells, no demonstrable tissue edema or neutrophil infiltration was noted. However, these findings do not absolutely prove that mast cells are the cells responsible for this effect. For example, some other defect resulting from W mutations could theoretically account for the difference seen between +/+ and mast cell-deficient KitW/KitW-v mice.
To further investigate the role of mast cells in this reaction and
whether mast cell-substance P interactions occurred via a mechanism
utilizing the NK1R, we reconstituted mast cell-deficient KitW/KitW-v mice with bone marrow
cells derived from NK1R-deficient mice. This unique animal model
permitted us to examine the reaction in a tissue milieu where only the
mast cell was deficient in NK1R expression. We found that inflammation
induced by substance P was similar in BMR-NK1R/
compared with normal +/+ mice. This finding provides definitive proof
that mast cells are essential for substance P-induced bladder inflammation and that NK1Rs on mast cells are not required.
At this time, we do not know the mechanism involved in mast cell activation by substance P in the bladder. Clearly, NK1Rs are not involved; however, NK2R may play a role. In guinea pigs, an NK2R-dependent mechanism has been suggested in the activation of lung mast cells by substance P (51). Alternatively, a receptor-independent mechanism may be involved (52). In either case, it is important to emphasize that our results pertain to murine mast cells in the bladder, and given the known heterogeneity that exists in mast cell populations, these results should not be generalized to other anatomic sites or species.
We observed that 50% of sensitized mice bearing NK1R/
mast cells died as a consequence of intravesical antigen
challenge. In more than six years of research challenging
sensitized mice with intravesical antigen administration, this was the
first time that we lost mice to anaphylaxis. Our previous work
indicates that this outcome was not observed when mast cells from
wild-type mice were used to reconstitute the mast cell-deficient mice
(72). However, NK1R
/
mice have at
least three times more mast cells in the urinary bladder
(73), and the same is valid in the stomach and esophagus (Saban R, unpublished observations). It is not clear why the absence of
substance P receptors would lead to an increase in tissue mast cell
numbers (72). Together with the present findings, our data strongly indicate that mast cells from NK1R
/
mice
present an overwhelming response to antigen stimulation. Future studies
are necessary to fully explain the differences between wild-type and
NK1R
/
mast cells.
We next focused our attention on the genes expressed during experimental bladder inflammation. For this purpose, we examined gene expression in antigen- and substance P-induced cystitis, both of which we have now characterized as mast cell-dependent forms of inflammation (72). We found that there were more mast cell-dependent genes expressed during substance P responses than in antigen-induced bladder inflammation; i.e., only 13 genes were upregulated in KitW/KitW-v mice during antigen-induced reactions compared with 128 genes upregulated during responses to substance P. This is not entirely unexpected because relatively few cell types express IgE receptors compared with multiple immune and nonimmune cells that express receptors capable of interacting with substance P.
Although our results indicate that an NK1R on the mast cell is not
necessary for the communication between sensory nerves and this immune
cell, others have presented indirect evidence that activation of PMNs
by substance P requires NK1Rs. In this instance, substance P primes
PMNs exposed to recombinant IL-8 and suggested that substance P-priming
effects are receptor mediated (24). In addition, substance
P activates PMNs to release cytokines such as TNF- and
interferon-
, and this effect is potentiated by bacterial LPS
(70). However, further studies using adequate animal
models such as the one described in the present work are necessary to
definitively access the role of neurokinin receptors on inflammatory cells.
In normal +/+ or BMR-NK1R/
mice, only four mast
cell-dependent genes were upregulated by either substance P or antigen.
Those included Spi 2.2, maspin, MSK2, and M-CSF (or CSF-1).
Interestingly, all four genes modulate inflammatory responses.
M-CSF (or CSF-1) acts to regulate the development and function of cells of the macrophage lineage (19). Macrophages are involved in inflammatory responses and, on treatment with M-CSF, displayed greater secretion of IL-6 (5). It was suggested that IL-6 occupies a central role in the CSF-1-regulated macrophage response to infection (36). In addition, it was suggested that the interplay between IL-6 and M-CSF switches monocyte differentiation to macrophages rather than dendritic cells and that IL-6 is an essential factor in the molecular control of antigen-presenting cell development (17).
Spi 2.2 is a member of the serpin gene family (74). In terms of physiological regulation of rat Spi 2.1 and 2.2 mRNAs, Spi 2.1 is dependent on growth hormone (GH) for maximal mRNA content (48, 94), whereas Spi 2.2 mRNA is not GH dependent (74). Spi 2 not only acts as a basal promoter element but also mediates transcriptional activation by GH and IL-6 (50). Spi 2 is known to be associated with proinflammatory processes. In the liver, Spi 2 genes have been correlated with the acute-phase response (8). These effects are mediated by the products of stimulated monocytes and macrophages in combination with glucocorticoids (7). In rat hepatocytes, turpentine induced an acute-phase response and an increase in Spi 2.2 expression, which was mediated primarily by IL-6 (7). The role of IL-6 on Spi 2.2 upregulation in the bladder should be further pursued because this cytokine is consistently elevated in patients with cystitis (26).
Maspin, another serine protease inhibitor related to the serpin family, is a secreted protein encoded by a class II tumor suppressor gene, whose downregulation is associated with the development of breast and prostate cancers (54). Maspin is associated with tumorigenesis, inflammation, and protection from autolysis by granule proteinases (75). Maspin interacts with the p53 tumor-suppressor pathway and functions as an inhibitor of angiogenesis in vitro and in vivo (96).
MSK2 is a novel protein kinase that is activated in vitro and in vivo by either MAPK/ERKs or SAPK2/p38. MSK1 (and/or MSK2) mediates activation of the transcription factors calcium/cAMP response element binding protein and activating transcription factor 1 by either growth factors or stress signals (20). Others have shown that substance P activates MAPKs (15) and, at nanomolar concentrations, induces the human astrocytoma cell line U373 MG to produce IL-6 by a p38 MAPK-dependent pathway (29).
The result of upregulation of proteases such as Spi 2.2 and maspin, SAPK, and CSF-1 by either substance P- or antigen-induced responses indicates a common mast cell-dependent pathway involved in acute bladder inflammation. These results suggest that activation of mast cells initiates activation of monocytes and/or macrophages and their resulting products such as IL-6 may modulate bladder inflammation.
There are several available methods for the analysis of gene microarray data, based on different mathematical assumptions and algorithms. Each of the analysis methods has advantages and limitations (65, 76).
An increasingly common approach involves using gene expression behavior observed over multiple experiments to first cluster genes together into groups, either by manually examining the data (16) or by using statistical methods such as SOMs (80), K-means clustering, or hierarchical clustering (25, 78). K-means clustering is a completely unstructured approach, which proceeds in an entirely local fashion and produces an unorganized collection of clusters that is not conducive to interpretation (80). Several recent papers employed hierarchical clustering algorithms to organize genes into a phylogenetic tree, reflecting similarity in expression patterns. However, the interpretation of these clusters is left to the observer.
We preferred to use SOMs because they are potent tools for identifying clusters involved in biologically related pathways and mechanisms (25, 69, 80, 82). The basic assumption underlying this unsupervised analysis is that genes with similar expression behavior (for example, increasing and decreasing together under similar circumstances) are likely to be related functionally. Although not logically rigorous, the utility of the cluster approach has been demonstrated, as genes already known to be related do, in fact, tend to cluster together based on their experimentally determined expression patterns (69). The validity of this approach has been demonstrated for many genes in Saccharomyces cerevisiae, a simple organism for which the entire genomic sequence and the functional roles of ~60% of the genes are known (25, 91). One limitation of SOMs is that genes negatively associated are not clustered.
SOMs can be performed by using Cluster software (http://rana.lbl.gov/) developed by Michael Eisen's laboratory or GeneSpring (http://www.silicongenetics.com/cgi/SiG.cgi/index.smf.), which permit the calculation of SOMs, K-means, and principal component analysis on the same set of data. The reason for the use of SOMs with GeneCluster software developed by Tamayo et al. (80) is that it performs the analytical calculations and provides easy data visualization. The approach is made more systematic and statistically sound by calculating the probability that the observed functional distribution of differentially expressed genes could have happened by chance. The application of statistical rigor is essential to avoid overly subjective interpretations of the results based on the predispositions, prior knowledge, and interests of the individual researcher (49). The power of cluster analysis was enhanced in the present work by the use of an excellent biological paradigm and a stringent criterion for cluster selection.
To fairly interpret gene cluster analysis, we must be cognizant of a growing body of evidence of mechanisms that control the rate of synthesis and half-life of proteins (31) and that gene and protein changes can be dissociated (31, 37). Future proteomic correlation must determine how directly mRNA changes reflect translated protein levels and the physiological consequence of these proteins.
In conclusion, our results confirm a mandatory role of mast cells in
substance P-induced bladder inflammation in mice and suggest that mast
cells mediate inflammation and gene regulation in the absence of NK1Rs
on its cell surface. The cDNA array experimental approach provides a
global profile of gene expression changes in bladder tissue after
stimulation with antigen or substance P. SOMs identified functionally
significant gene clusters. These gene expression responses may
represent a balance between the cytoprotective and inflammatory
processes that accompany bladder response to injury. Gene
cluster analysis techniques can be applied in the future to begin to
understand clinically relevant issues, such as how and why the
transition from acute to chronic inflammation occurs only under
selected circumstances and which therapeutic strategies can be used to
selectively target genes expressed in bladder inflammation. However,
cluster analysis and gene array profiling will have a strong impact
whenever unique animal models such as
KitW/KitW-v, BMR, and
BMR-NK1R/
are included, which allow establishment of
biological paradigms to be tested.
![]() |
ACKNOWLEDGEMENTS |
---|
This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grants DK-55828-01 (R. Saban), DK-46819 (B. K. Wershil), and DK-33506 (B. K. Wershil) and National Heart, Lung, and Blood Institute Grant HL-41587 (N. P. Gerard).
![]() |
FOOTNOTES |
---|
Address for reprint requests and other correspondence: R. Saban, Dept. of Physiology, College of Medicine, Univ. of Oklahoma Health Sciences Center (OUHSC), 940 SL Young Blvd., Rm. 605, Oklahoma City, OK 73104-0505 (E-mail: ricardo-saban{at}ouhsc.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
May 22, 2002;10.1152/ajprenal.00096.2002
Received 12 March 2002; accepted in final form 9 May 2002.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1.
Abbadie, C,
Brown JL,
Mantyh PW,
and
Basbaum AI.
Spinal cord substance P receptor immunoreactivity increases in both inflammatory and nerve injury models of persistent pain.
Neuroscience
70:
201-209,
1996[ISI][Medline].
2.
Aridor, M,
Traub LM,
and
Sagi-Eisenberg R.
Exocytosis in mast cells by basic secretagogues: evidence for direct activation of GTP-binding proteins.
J Cell Biol
111:
909-917,
1990[Abstract].
3.
Baker, PM,
and
Young RH.
Radiation-induced pseudocarcinomatous proliferations of the urinary bladder: a report of 4 cases.
Human Pathol
31:
678-683,
2000[ISI][Medline].
4.
Beaujouan, JC,
Saffroy M,
Torrens Y,
and
Glowinski J.
Potency and selectivity of the tachykinin NK3 receptor antagonist SR 142801.
Eur J Pharmacol
319:
307-316,
1997[ISI][Medline].
5.
Bernier, T,
Tschernig T,
Pabst R,
Macke O,
Steinmueller C,
and
Emmendorffer A.
Effects of macrophage-CSF on pulmonary-macrophage repopulation after bone marrow transplantation.
J Leukoc Biol
70:
39-45,
2001
6.
Bernstein, PR,
Aharony D,
Albert JS,
Andisik D,
Barthlow HG,
Bialecki R,
Davenport T,
Dedinas RF,
Dembofsky BT,
Koether G,
Kosmider BJ,
Kirkland K,
Ohnmacht CJ,
Potts W,
Rumsey WL,
Shen L,
Shenvi A,
Sherwood S,
Stollman D,
and
Russell K.
Discovery of novel, orally active dual NK1/NK2 antagonists.
Bioorg Med Chem Lett
11:
2769-2773,
2001[ISI][Medline].
7.
Berry, SA,
Bergad PL,
and
Bundy MV.
Expression of growth hormone-responsive serpin messenger RNAs in perinatal rat liver.
Am J Physiol Endocrinol Metab
264:
E973-E980,
1993
8.
Berry, SA,
Bergad PL,
Stolz AM,
Towle HC,
and
Schwarzenberg SJ.
Regulation of Spi 2.1 and 2.2 gene expression after turpentine inflammation: discordant responses to IL-6.
Am J Physiol Cell Physiol
276:
C1374-C1382,
1999
9.
Bester, H,
De Felipe C,
and
Hunt SP.
The NK1 receptor is essential for the full expression of noxious inhibitory controls in the mouse.
J Neurosci
21:
1039-1046,
2001
10.
Bhan, R,
Pisharodi LR,
Gudlaugsson E,
and
Bedrossian C.
Cytological, histological, and clinical correlations in intravesical bacillus Calmette-Guerin immunotherapy.
Ann Diagn Pathol
2:
55-60,
1998[Medline].
11.
Bjorling, DE,
Saban MR,
and
Saban R.
Neurogenic inflammation of the guinea pig bladder.
Mediators Inflamm
3:
189-197,
1994[ISI].
12.
Bohle, A.
BCG's mechanism of actionincreasing our understanding. For the EBIN Group.
Eur Urol
37, Suppl1:
1-8,
2000.
13.
Boone, CW,
and
Kelloff GJ.
Endpoint markers for clinical trials of chemopreventive agents derived from the properties of epithelial precancer (intraepithelial neoplasia) measured by computer-assisted image analysis.
Cancer Surv
32:
133-147,
1998[ISI][Medline].
14.
Bozic, CR,
Lu B,
Hopken UE,
Gerard C,
and
Gerard NP.
Neurogenic amplification of immune complex inflammation.
Science
273:
1722-1725,
1996
15.
Castagliuolo, I,
Valenick L,
Liu J,
and
Pothoulakis C.
Epidermal growth factor receptor transactivation mediates substance P-induced mitogenic responses in U-373 MG cells.
J Biol Chem
275:
26545-26550,
2000
16.
Cho, RJ,
Campbell MJ,
Winzeler EA,
Steinmetz L,
Conway A,
Wodicka L,
Wolfsberg TG,
Gabrielian AE,
Landsman D,
Lockhart DJ,
and
Davis RW.
A genome-wide transcriptional analysis of the mitotic cell cycle.
Mol Cell
2:
65-73,
1998[ISI][Medline].
17.
Chomarat, P,
Banchereau J,
Davoust J,
and
Palucka AK.
IL-6 switches the differentiation of monocytes from dendritic cells to macrophages.
Nat Immun
1:
510-514,
2000[ISI].
18.
Cooke, HJ,
Fox P,
Alferes L,
Fox CC,
and
Wolfe SA, Jr.
Presence of NK1 receptors on a mucosal-like mast cell line, RBL-2H3 cells.
Can J Physiol Pharmacol
76:
188-193,
1998[ISI][Medline].
19.
Csar, XF,
Wilson NJ,
McMahon KA,
Marks DC,
Beecroft TL,
Ward AC,
Whitty GA,
Kanangasundarum V,
and
Hamilton JA.
Proteomic analysis of macrophage differentiation. p46/52(Shc) Tyrosine phosphorylation is required for CSF-1-mediated macrophage differentiation.
J Biol Chem
276:
26211-26217,
2001
20.
Deak, M,
Clifton AD,
Lucocq LM,
and
Alessi DR.
Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB.
EMBO J
3:
4426-4441,
1988.
21.
De Garavilla, L,
Vergnolle N,
Young SH,
Ennes H,
Steinhoff M,
Ossovskaya VS,
D'Andrea MR,
Mayer EA,
Wallace JL,
Hollenberg MD,
Andrade-Gordon P,
and
Bunnett NW.
Agonists of proteinase-activated receptor 1 induce plasma extravasation by a neurogenic mechanism.
Br J Pharmacol
133:
975-987,
2001
22.
Delnay, KM,
Stonehill WH,
Goldman H,
Jukkola AF,
and
Dmochowski RR.
Bladder histological changes associated with chronic indwelling urinary catheter.
J Urol
161:
1106-1108,
1999[ISI][Medline].
23.
De Seze, M,
Wiart L,
Joseph PA,
Dosque JP,
Mazaux JM,
and
Barat M.
Capsaicin and neurogenic detrusor hyperreflexia: a double-blind placebo-controlled study in 20 patients with spinal cord lesions.
Neurourol Urodyn
17:
513-523,
1998[ISI][Medline].
24.
Dianzani, C,
Lombardi G,
Collino M,
Ferrara C,
Cassone MC,
and
Fantozzi R.
Priming effects of substance P on calcium changes evoked by interleukin-8 in human neutrophils.
J Leuk Biol
69:
1013-1018,
2001
25.
Eisen, MB,
Spellman PT,
Brown PO,
and
Botstein D.
Cluster analysis and display of genome-wide expression patterns.
Proc Natl Acad Sci USA
95:
14863-14868,
1998
26.
Erickson, DR,
Belchis DA,
and
Dabbs DJ.
Inflammatory cell types and clinical features of interstitial cystitis.
J Urol
158:
790-793,
1997[ISI][Medline].
27.
Everitt, BS,
Landau S,
and
Leese M.
Cluster Analysis (4th ed.). New York: Oxford University Press, 2001.
28.
Fall, M,
Johansson SL,
and
Aldenborg F.
Chronic interstitial cystitis: a heterogeneous syndrome.
J Urol
137:
35-38,
1987[ISI][Medline].
29.
Fiebich, BL,
Schleicher S,
Butcher RD,
Craig A,
and
Lieb K.
The neuropeptide substance P activates p38 mitogen-activated protein kinase resulting in IL-6 expression independently from NF-kappa B.
J Immunol
165:
5606-5611,
2000
30.
Furuta, GT,
Schmidt-Choudhury A,
Wang MY,
Wang ZS,
Lu L,
Furlano RI,
and
Wershil BK.
Mast cell-dependent tumor necrosis factor alpha production participates in allergic gastric inflammation in mice.
Gastroenterology
113:
1560-1569,
1997[ISI][Medline].
31.
Futcher, B,
Latter GI,
Monardo P,
McLaughlin CS,
and
Garrels JI.
A sampling of the yeast proteome.
Mol Cell Biol
19:
7357-7368,
1999
32.
Galli, SJ.
New concepts about the mast cell.
N Engl J Med
328:
257-265,
1993
33.
Gao, GC,
and
Wei ET.
Inhibition of substance P-induced vascular leakage in rat by N-acetyl-neurotensin-(8-13).
Regul Pept
58:
117-121,
1995[ISI][Medline].
34.
Giannantoni, A,
Di Stasi S,
Stephen RL,
Navarra P,
Scivoltetto G,
Mearini E,
and
Porena M.
Intravesical capsaicin versus resinferatoxin in patients with detrusor hyperreflexia: A prospective randomized study.
J Urol
167:
1710-1714,
2002[ISI][Medline].
35.
Grady, EF,
Baluk P,
Bohm S,
Gamp PD,
Wong H,
Payan DG,
Ansel J,
Portbury AL,
Furness JB,
McDonald DM,
and
Bunnett NW.
Characterization of antisera specific to NK1, NK2, and NK3 neurokinin receptors and their utilization to localize receptors in the rat gastrointestinal tract.
J Neurosci
16:
6975-6986,
1996
36.
Guleria, I,
and
Pollard JW.
Aberrant macrophage and neutrophil population dynamics and impaired Th1 response to Listeria monocytogenes in colony-stimulating factor 1-deficient mice.
Infect Immun
69:
1795-1807,
2001
37.
Gygi, S,
Rochon Y,
Franza BR,
and
Aebersold R.
Correlation between protein and mRNA abundance in yeast.
Mol Cell Biol
19:
1720-1730,
1999
38.
Haak-Frendscho, M,
Saban R,
Shields R,
and
Jardieu P.
Blockade of histamine release and tissue contraction by antibodies to IgE in an established IgE response.
Immunology
94:
115-121,
1998[ISI][Medline].
39.
Hammond, TG,
Saban R,
Bost KL,
Harris HW, Jr,
Kaysen JH,
Goda FO,
Navar GL,
Bjorling DE,
Saban M,
and
Zeidel ML.
Inhibition of endosomal fusion during bladder inflammation is substance P dependent.
Am J Physiol Renal Physiol
278:
F440-F450,
2000
40.
Hanno, PM,
Landis JR,
Matthews-Cook Y,
Kusek J,
and
Nyberg L, Jr.
The diagnosis of interstitial cystitis revisited:lessons learned from the National Institutes of Health Interstitial Cystitis Database study.
J Urol
161:
553-557,
1999[ISI][Medline].
41.
Hill, R.
NK1 (substance P) receptor antagonistswhy are they not analgesic in humans?
Trends Pharmacol Sci
21:
244-246,
2000[ISI][Medline].
42.
Hohenfellner, M,
Nunes L,
Schmidt RA,
Lampela A,
Thuroff JW,
and
Tanagho EA.
Interstitial cystitis: increased sympathetic innervation and related neuropeptide synthesis.
J Urol
147:
587-591,
1992[ISI][Medline].
43.
Jackson, AM,
Ivshina AV,
Senko O,
Kuznetsova A,
Sundan A,
O'Donnell MA,
Clinton S,
Alexandroff AB,
Selby PJ,
James K,
and
Kuznetsov VA.
Prognosis of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer by immunological urinary measurements: statistically weighted syndrome analysis.
J Urol
159:
1054-1063,
1998[ISI][Medline].
44.
Kamp, EH,
Beck DR,
and
Gebhart GF.
Combinations of neurokinin receptor antagonists reduce visceral hyperalgesia.
J Pharmacol Exp Ther
299:
105-113,
2001
45.
Karlsson, JA,
Souness J,
Webber S,
Pollock K,
and
Raeburn D.
Anti-inflammatory effects of the novel phosphodiesterase IV inhibitor RP 73401.
Int Arch Allergy Immunol
107:
5-6,
1995.
46.
Krumins, SA,
and
Broomfield CA.
Evidence of NK1 and NK2 tachykinin receptors and their involvement in histamine release in a murine mast cell line.
Neuropeptides
21:
65-72,
1992[ISI][Medline].
47.
Laird, JM,
Roza C,
De Felipe C,
Hunt SP,
and
Cervero F.
Role of central and peripheral tachykinin NK1 receptors in capsaicin-induced pain and hyperalgesia.
Pain
90:
97-103,
2001[ISI][Medline].
48.
Le Cam, A,
Pages G,
Auberger P,
Le Cam G,
Leopold P,
Benarous R,
and
Glaichenhaus N.
Study of a growth hormone regulated protein secreted by rat hepatocytes: cDNA cloning,anti-protease activity and regulation of its synthesis by various hormones.
EMBO J
6:
1225-1132,
1987[Abstract].
49.
Lee, MLT,
Kuo FC,
Whitmore GA,
and
Sklar J.
Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations.
PNAS
97:
9834-9839,
2000
50.
Leverrier, S,
Cinato E,
Paul C,
Derancourt J,
Bemark M,
Leanderson T,
and
Legraverend C.
Purification and cloning of type A/B hnRNP proteins involved in transcriptional activation from the Rat spi 2 gene GAGA box.
Biol Chem
381:
1031-1040,
2000[ISI][Medline].
51.
Lilly, CM,
Hall AE,
Rodger IW,
Kobzik L,
Haley KJ,
and
Drazen JM.
Substance P-induced histamine release in tracheally perfused guinea pig lungs.
J Appl Physiol
78:
1234-1241,
1995
52.
Little, SR,
and
Eisen AN.
Preparation of immunogenic 2, 4-dinitrophenyl and 2, 4, 6-trinitrophenyl proteins.
Methods Immunol Immunochem
1:
128-133,
1967.
53.
Lorenz, D,
Wiesner B,
Zipper J,
Winkler A,
Krause E,
Beyermann M,
Lindau M,
and
Bienert M.
Mechanism of peptide-induced mast cell degranulation. Translocation and patch-clamp studies.
J Gen Physiol
112:
577-591,
1998
54.
Maass, N,
Hojo T,
Zhang M,
Sager R,
Jonat W,
and
Nagasaki K.
Maspina novel protease inhibitor with tumor-suppressing activity in breast cancer.
Acta Oncologica
39:
931-934,
2000[Medline].
55.
Marchand, JE,
Sant GR,
and
Kream RM.
Increased expression of substance P receptor-encoding mRNA in bladder biopsies from patients with interstitial cystitis.
Br J Urol
81:
224-228,
1998[ISI][Medline].
56.
Mussap, CJ,
Stamatakos C,
and
Burcher E.
Radioligand binding, autoradiographic and functional studies demonstrate tachykinin NK-2 receptors in dog urinary bladder.
J Pharmacol Exp Ther
279:
423-434,
1996[Abstract].
57.
Nsa Allogho, S,
Nguyen-Le XK,
Gobeil F,
Pheng LH,
and
Regoli D.
Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study.
Can J Physiol Pharmacol
75:
552-557,
1997[ISI][Medline].
58.
Ogawa, K,
Nabe T,
Yamamura H,
and
Kohno S.
Nanomolar concentrations of neuropeptides induce histamine release from peritoneal mast cells of a substrain of Wistar rats.
Eur J Pharmacol
18:
285-291,
1999.
59.
Okada, T,
Hirayama Y,
Kishi S,
Miyayasu K,
Hiroi J,
and
Fuji T.
Functional neurokinin NK-1 receptor expression in rat peritoneal mast cells.
Inflamm Res
48:
274-279,
1999[ISI][Medline].
60.
Okamoto, M,
Hattori K,
and
Oyasu R.
Interleukin-6 functions as an autocrine growth factor in human bladder carcinoma cell lines in vitro.
Int J Cancer
72:
149-154,
1997[ISI][Medline].
61.
Pahl, HL.
Activators and target genes of Rel/NF-B transcription factors.
Oncogene
18:
6853-6866,
1999[ISI][Medline].
62.
Pang, X,
Marchand J,
Sant GR,
and
Theoharides TC.
Increased number of SP-positive fibres in interstitial cystitis.
Br J Urol
75:
744-750,
1995[ISI][Medline].
63.
Patacchini, R,
Giuliani S,
Turini A,
Navarra G,
and
Maggi CA.
Effect of nepadutant at tachykinin NK(2) receptors in human intestine and urinary bladder.
Eur J Pharmacol
398:
389-397,
2000[ISI][Medline].
64.
Peeker, R,
Enerback L,
Fall M,
and
Aldenborg F.
Recruitment, distribution and phenotypes of mast cells in interstitial cystitis.
J Urol
163:
1009-1015,
2000[ISI][Medline].
65.
Quackenbush, J.
Computational analysis of microarray data.
Nat Rev Genet
2:
418-427,
2001[ISI][Medline].
66.
Rayet, B,
and
Gelinas C.
Aberrant rel/NF-B genes and activity in human cancer.
Oncogene
18:
6938-6947,
1999[ISI][Medline].
67.
Reichard, GA,
Ball ZT,
Aslanian R,
Anthes JC,
Shih NY,
and
Piwinski JJ.
The design and synthesis of novel NK1/NK2 dual antagonists.
Bioorg Med Chem Lett
10:
2329-2332,
2000[ISI][Medline].
68.
Rosamilia, A,
Cann L,
Dwyer P,
Scurry J,
and
Rogers P.
Bladder microvasculature in women with interstitial cystitis.
J Urol
161:
1865-1870,
1999[ISI][Medline].
69.
Saban, MR,
Hellmich H,
Nguyen NB,
Winston J,
Hammond TG,
and
Saban R.
Time course of LPS-induced gene-expression in a mouse model of genitourinary inflammation.
Physiol Genom
5:
147-160,
2001
70.
Saban, MR,
Saban R,
Hammond TG,
Haak-Frendscho M,
Steinberg H,
Tengowski MW,
and
Bjorling DE.
LPS-sensory peptide communication in experimental cystitis.
Am J Physiol Renal Physiol
282:
F202-F210,
2002
71.
Saban, R,
Nielsen KT,
Rhodes PR,
Christensen MM,
and
Bruskewitz RC.
Effects of mucosa removal and an enkephalinase inhibitor on the contractions of dog isolated bladder strips.
J Urol
147:
750-755,
1992[ISI][Medline].
72.
Saban, R,
Saban MR,
Nguyen NB,
Hammond TG,
and
Wershil BK.
Mast cell regulation of inflammation and gene-expression during antigen-induced bladder inflammation in the mouse.
Physiol Genom
7:
35-44,
2001[Medline].
73.
Saban, R,
Saban MR,
Nguyen NB,
Lu B,
Gerard C,
Gerard NP,
and
Hammond TG.
Neurokinin-1 (NK-1) receptor is required in antigen-induced cystitis.
Am J Pathol
156:
775-780,
2000
74.
Schwarzenberg, SJ,
Yoon JB,
Seelig S,
Potter CJ,
and
Berry SA.
Discoordinate hormonal and ontogenetic regulation of four rat serpin genes.
Am J Physiol Cell Physiol
262:
C1144-C1148,
1992
75.
Scott, FL,
Eyre HJ,
Lioumi M,
Ragoussis J,
Irving JA,
Sutherland GA,
and
Bird PI.
Human ovalbumin serpin evolution: phylogenic analysis, gene organization, and identification of new PI8-related genes suggest that two inter-chromosomal and several intra-chromosomal duplications generated the gene clusters at 18q21-q23 and 6p25.
Genomics
62:
490-499,
1999[ISI][Medline].
76.
Sherlock, G.
Analysis of large-scale gene expression data.
Curr Opin Immunol
12:
201-205,
2000[ISI][Medline].
77.
Shih, NY,
Albanese M,
Anthes JC,
Carruthers NI,
Grice CA,
Lin L,
Mangiaracina P,
Reichard GA,
Schwerdt J,
Seidl V,
Wong SC,
and
Piwinski JJ.
Synthesis and structure-activity relationships of oxime neurokinin antagonists: discovery of potent arylamides.
Bioorg Med Chem Lett
12:
141-145,
2002[ISI][Medline].
78.
Spellman, PT,
Sherlock G,
Zhang MQ,
Iyer VR,
Anders K,
Eisen MB,
Brown PO,
Botstein D,
and
Futcher B.
Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization.
Mol Biol Cell
9:
3273-3297,
1998
79.
Syrigos, KN,
Harrington KJ,
and
Pignatelli M.
Role of adhesion molecules in bladder cancer: an important part of the jigsaw.
Urology
53:
428-434,
1999[ISI][Medline].
80.
Tamayo, P,
Slonim D,
Mesirov J,
Zhu Q,
Kitareewan S,
Dmitrovsky E,
Lander ES,
and
Golub TR.
Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation.
PNAS
96:
2907-2912,
1999
81.
Theoharides, TC,
Pang X,
Letourneau R,
and
Sant GR.
Interstitial cystitis: a neuroimmunoendocrine disorder.
Ann NY Acad Sci
840:
619-634,
1998
82.
Toronen, P,
Kolehmainen M,
Wong G,
and
Castren E.
Analysis of gene expression data using self-organizing maps.
FEBS Lett
451:
142-146,
1999[ISI][Medline].
83.
Tramontana, M,
Patacchini R,
Lecci A,
Giuliani S,
and
Maggi CA.
Tachykinin NK2 receptors in the hamster urinary bladder: in vitro and in vivo characterization.
Naunyn-Schmiedebergs Arch Pharmacol
358:
293-300,
1998[ISI][Medline].
84.
Urban, LA,
and
Fox AJ.
NK1 receptor antagonistsare they really without effect in the pain clinic?
Trends Pharmacol Sci
21:
462-464,
2000[ISI][Medline].
85.
Van Giersbergen, PLM,
and
Buck SH.
Characterization of tachykinin receptors.
In: The Tachykinin Receptors, edited by Buck SH.. Totowa, NJ: Humana, 1994, p. 39-68.
86.
Vizzard, MA.
Alterations in neuropeptide expression in lumbosacral bladder pathways following chronic cystitis.
J Chem Neuroanat
21:
125-138,
2001[ISI][Medline].
87.
Vizzard, MA.
Up-regulation of pituitary adenylate cyclase-activating polypeptide in urinary bladder pathways after chronic cystitis.
J Comp Neurol
420:
335-348,
2000[ISI][Medline].
88.
Wall, BM,
Dmochowski RR,
Malecha M,
Mangold T,
Bobal MA,
and
Cooke CR.
Inducible nitric oxide synthase in the bladder of spinal cord injured patients with a chronic indwelling urinary catheter.
J Urol
165:
1457-1461,
2001[ISI][Medline].
89.
Wang, XC,
Saban R,
Kaysen JH,
Saban MR,
Allen PL,
Benes EN,
and
Hammond TG.
Nuclear factor kappa B mediates lipopolysaccharide-induced inflammation in the urinary bladder.
J Urol
163:
993-998,
2000[ISI][Medline].
90.
Watson, S,
and
Arkinstall S.
The G Protein-Linked Receptor, edited by Watson S,
and Arkinstall S.. New York: Academic, 1994, p. 261-271.
91.
Wen, X,
Fuhrman S,
Michaels GS,
Carr DB,
Smith S,
Barker JL,
and
Somogyi R.
Large-scale temporal gene expression mapping of central nervous system development.
PNAS
95:
334-339,
1998
92.
Wershil, B.
Mast cell-deficient mice and intestinal biology.
Am J Physiol Gastrointest Liver Physiol
278:
G343-G348,
2000
93.
Yano, H,
Wershil BK,
Arizono N,
and
Galli SJ.
Substance P-induced augmentation of cutaneous vascular permeability and granulocyte infiltration in mice is mast cell dependent.
J Clin Invest
84:
1276-1286,
1989[ISI][Medline].
94.
Yoon, JB,
Towle HC,
and
Seelig S.
Growth hormone induces two mRNA species of the serine protease inhibitor gene family in rat liver.
J Biol Chem
262:
4284-4289,
1987
95.
Zeng, XP,
and
Burcher E.
Tachykinin NK-2 receptors in child urinary bladder.
J Urol
155:
1104-1107,
1996[ISI][Medline].
96.
Zhang, M,
Volpert O,
Shi YH,
and
Bouck N.
Maspin is an angiogenesis inhibitor.
Nat Med
6:
196-199,
2000[ISI][Medline].